ArticleMaterials today. Bio2026
3D coaxial bioprinting of RADA16-I self-assembling peptide hydrogel.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fundamentals and Advances in Programmable Peptide Hydrogels for Multifunctional Biomedical Applications: A Review.Gels (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peptides that self-assemble into hydrogels provide a dynamic microenvironment for various cell types. Combining top-down extrusion 3D bioprinting with bottom-up self-assembly of peptide hydrogels offers an innovative approach to biofabrication. However, modest mechanical properties of peptide hydrogels pose challenges for extrusion 3D bioprinting. This study introduces RADA16-I peptide hydrogels for bioprinting by leveraging the potential of coaxial extrusion to print mechanically soft hydrogels. A coaxial 3D bioprinter was employed to co-extrude a RADA16-I peptide core supplemented with methylcellulose (MC) and sucrose, surrounded by an MC-alginate composite hydrogel shell. The phosphate-buffered MC-alginate shell provides stability and initiates the RADA16-I hydrogel self-assembly post-extrusion. Rheological characterization confirmed the increase in viscosity of the RADA16-I core solution without compromising self-assembly (G' ≈ 100 Pa). Core extrusion ratio was set to 20% to balance filament stability and soft-core content. Printed scaffolds maintained excellent shape fidelity and structural integrity over a 21-day culture period, with gradual MC release (≈90%) creating an open-porous shell structure. Mesenchymal stem cells (MSCs) encapsulated in the RADA-MC core hydrogel tended to aggregate, forming a dense collagen network with calcium phosphate deposition. Bioprinted cell-laden scaffolds displayed a homogeneous distribution of viable cells (>90%). In conclusion, this approach successfully introduced self-assembling peptide hydrogels to bioprinting technology, offering a promising strategy for biofabrication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.